AEON Biopharma Quote - AEON

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.6163

Bid

Ask

Volume

149,993

0.58 Day's Range 0.64

0.5206 52 Week Range 17.17

Market Cap

24.634M

Previous Close

0.6495

Open

0.63

Last Trade

138

0.6163

Last Trade Time

12:54:12

Financial Volume

US$ 92,719

VWAP

0.618154

Average Volume (3m)

203,580

Shares Outstanding

39,970,693

Dividend Yield

PE Ratio

1.05

Earnings Per Share (EPS)

0.6

Revenue

52.75M

Net Profit

24.05M

AEON Biopharma, Inc. is a bio-pharmaceutical company. The Company is focused on developing ABP-450 (prabotulinumtoxinA) injection for the treatment of debilitating medical conditions with an initial focus on the neurology and gastroenterology markets. ABP-450 contains a 900 kDa botulinum toxin type-... AEON Biopharma, Inc. is a bio-pharmaceutical company. The Company is focused on developing ABP-450 (prabotulinumtoxinA) injection for the treatment of debilitating medical conditions with an initial focus on the neurology and gastroenterology markets. ABP-450 contains a 900 kDa botulinum toxin type-A complex produced by the bacterium clostridium botulinum. The active part of the botulinum toxin is the 150 kDa component, and the remaining 750 kDa of the complex is made up of accessory proteins. When injected at therapeutic levels, ABP-450 blocks peripheral acetylcholine release at presynaptic cholinergic nerve terminals by cleaving SNAP-25, a protein integral to the docking and release of acetylcholine from vesicles situated within the nerve endings leading to denervation and relaxation of the muscle. It is also engaged in the Phase II clinical study of ABP-450 for the treatment of cervical dystonia. Cervical dystonia, also known as spasmodic torticollis, is a neurological condition. Show more

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Headquarters

Wilmington, Delaware, USA

Founded

2022

AEON Biopharma Inc is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker AEON. The last closing price for AEON Biopharma was US$0.65. Over the last year, AEON Biopharma shares have traded in a share price range of US$ 0.5206 to US$ 17.17.

AEON Biopharma currently has 39,970,693 shares outstanding. The market capitalization of AEON Biopharma is US$25.96 million. AEON Biopharma has a price to earnings ratio (PE ratio) of 1.05.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0948	-13.331458304	0.7111	0.749799	0.58	131031	0.65366931	CS
4	0.0573	10.2504472272	0.559	0.9	0.5206	297108	0.68467827	CS
12	-0.2695	-30.4244750508	0.8858	1.6051	0.5206	203580	0.86306421	CS
26	-0.7537	-55.0145985401	1.37	3.74	0.5206	944501	2.26185822	CS
52	-5.4937	-89.9132569558	6.11	17.17	0.5206	512342	2.52248141	CS
156	-9.5237	-93.9220907298	10.14	17.17	0.5206	382995	2.72744055	CS
260	-9.5237	-93.9220907298	10.14	17.17	0.5206	382995	2.72744055	CS

AEON - Frequently Asked Questions (FAQ)

What is the current AEON Biopharma share price?

The current share price of AEON Biopharma is US$ 0.6163

How many AEON Biopharma shares are in issue?

AEON Biopharma has 39,970,693 shares in issue

What is the market cap of AEON Biopharma?

The market capitalisation of AEON Biopharma is USD 25.96M

What is the 1 year trading range for AEON Biopharma share price?

AEON Biopharma has traded in the range of US$ 0.5206 to US$ 17.17 during the past year

What is the PE ratio of AEON Biopharma?

The price to earnings ratio of AEON Biopharma is 1.05

What is the cash to sales ratio of AEON Biopharma?

The cash to sales ratio of AEON Biopharma is 0.48

What is the reporting currency for AEON Biopharma?

AEON Biopharma reports financial results in USD

What is the latest annual turnover for AEON Biopharma?

The latest annual turnover of AEON Biopharma is USD 52.75M

What is the latest annual profit for AEON Biopharma?

The latest annual profit of AEON Biopharma is USD 24.05M

What is the registered address of AEON Biopharma?

The registered address for AEON Biopharma is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801

Which industry sector does AEON Biopharma operate in?

AEON Biopharma operates in the BLANK CHECKS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MINFT Limited	US$ 7.74 (53.97%)	229.38k
MGLDMarygold Companies Inc	US$ 1.75 (26.81%)	63.45k
KULRKULR Technology Group Inc	US$ 2.76 (23.21%)	56.7M
GOROGold Resource Corporation	US$ 0.2718 (23.15%)	4.73M
CTMCastellum Inc	US$ 0.499899 (21.96%)	5.96M
BATLBattalion Oil Corporation	US$ 1.4701 (-39.63%)	969.8k
NVOXDefiance Daily Target 2x Long Nvo ETF	US$ 11.53 (-35.85%)	293.43k
TPETTrio Petroleum Corp	US$ 1.09 (-25.85%)	2.28M
UVIX2x Long VIX Futures ETF	US$ 4.04 (-25.19%)	54.85M
EXODExodus Movement Inc	US$ 40.84 (-19.84%)	8.25k
SPXSDirexion Daily S&P 500 Bear 3X Shares New	US$ 6.1101 (-4.08%)	89.7M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 27.62 (5.02%)	81.65M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2.225 (-1.98%)	67.66M
SPYSPDR S&P 500	US$ 592.38 (1.07%)	63.36M
KULRKULR Technology Group Inc	US$ 2.76 (23.21%)	56.7M